The impact of Module Continence Aids on costs and quality of life in patients with urine incontinence

To improve tailored prescription of continence aids, involved parties (patient associations, suppliers, pharmacists, health insurers) have developed a protocol: the Module Continence Aids (Dutch abbr.: Module CH). This module is recorded in the Generic Quality Framework for Medical Devices in the Register of the National Health Care Institute and will be introduced from 2018 onwards. It is unknown whether using the Module CH has an actual influence on the functioning of users, the extent of the use of incontinence aids and the associated costs. The factors that can improve or obstruct implementation are unknown as well. We want to investigate this in an observational care evaluation study in primary care, consisting of a before-after comparison. During the baseline measurement we collect information about the current functional status of users of absorbent incontinence aids, the use of continence aids and the costs associated with urine incontinence. Subsequently the Module CH is applied. The follow-up include the same measurements as used during the baseline measurement. In addition, we identify the factors that can improve or obstruct implementation using interviews with involved healthcare providers.

Implementation of Module CH leads to better tailored care, improved functioning of the user and more efficient use of absorbent incontinence aids.

- Baseline measurement
- Follow up after 3 months
- Follow up after 6 months

N/A